U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H28N2O
Molecular Weight 348.4812
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of IFERANSERIN

SMILES

CN1CCCC[C@H]1CCC2=CC=CC=C2NC(=O)\C=C\C3=CC=CC=C3

InChI

InChIKey=UXIPFQUBOVWAQW-UEBLJOKOSA-N
InChI=1S/C23H28N2O/c1-25-18-8-7-12-21(25)16-15-20-11-5-6-13-22(20)24-23(26)17-14-19-9-3-2-4-10-19/h2-6,9-11,13-14,17,21H,7-8,12,15-16,18H2,1H3,(H,24,26)/b17-14+/t21-/m0/s1

HIDE SMILES / InChI

Molecular Formula C23H28N2O
Molecular Weight 348.4812
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 1
Optical Activity UNSPECIFIED

PubMed

PubMed

TitleDatePubMed
Intra-anal Iferanserin 10 mg BID for hemorrhoid disease: a prospective, randomized, double-blind, placebo-controlled trial.
2012 Feb

Sample Use Guides

Intra-Anal Application of Iferanserin (10 mg) as a 0.5% Ointment
Route of Administration: Other
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:50:31 GMT 2023
Edited
by admin
on Sat Dec 16 17:50:31 GMT 2023
Record UNII
NWR3BEB8PA
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IFERANSERIN
INN  
INN  
Official Name English
2-PROPENAMIDE, N-(2-(2-((2S)-1-METHYL-2-PIPERIDINYL)ETHYL)PHENYL)-3-PHENYL-, (2E)-
Systematic Name English
iferanserin [INN]
Common Name English
(2E)-N-(2-(2-((2S)-1-METHYL-2-PIPERIDINYL)ETHYL)PHENYL)-3-PHENYL-2-PROPENAMIDE
Systematic Name English
(E)-2'-(2-((2S)-1-METHYL-2-PIPERIDYL)ETHYL)CINNAMANILIDE
Systematic Name English
S-MPEC
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 315910
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
NCI_THESAURUS C66885
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
Code System Code Type Description
PUBCHEM
6445539
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
PRIMARY
SMS_ID
300000036998
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107754
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
PRIMARY
DRUG BANK
DB11686
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
PRIMARY
NCI_THESAURUS
C90945
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
PRIMARY
CAS
58754-46-4
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
NON-SPECIFIC STEREOCHEMISTRY
FDA UNII
NWR3BEB8PA
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
PRIMARY
INN
8334
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
PRIMARY
CAS
951155-17-2
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
PRIMARY
MESH
C572904
Created by admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY